These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 22397637)

  • 21. Effect of skin-penetrating enhancers on the thermophysical properties of cholesteryl oleyl carbonate embedded in a thermo-responsive membrane.
    Lin SY; Li MJ; Lin HL
    J Mater Sci Mater Med; 2000 Nov; 11(11):701-4. PubMed ID: 15348075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liquid spray formulations of xibornol by using self-microemulsifying drug delivery systems.
    Cirri M; Mura P; Mora PC
    Int J Pharm; 2007 Aug; 340(1-2):84-91. PubMed ID: 17531411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanistic evaluation of the effect of thermal-treating on Eudragit RS matrices.
    Azarmi S; Ghaffari F; Löbenberg R; Nokhodchi A
    Farmaco; 2005; 60(11-12):925-30. PubMed ID: 16223498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development, in vitro and in vivo characterization of Eudragit RL 100 nanoparticles for improved ocular bioavailability of acetazolamide.
    Verma P; Gupta RN; Jha AK; Pandey R
    Drug Deliv; 2013; 20(7):269-76. PubMed ID: 24044644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. pH of preparations affecting the on-off drug penetration behavior through the thermo-responsive liquid crystal-embedded membrane.
    Lin SY; Chen KS; Lin YY
    J Control Release; 1998 Oct; 55(1):13-20. PubMed ID: 9795002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Temperature modulated drug permeation through liquid crystal embedded cellulose membranes.
    Atyabi F; Khodaverdi E; Dinarvand R
    Int J Pharm; 2007 Jul; 339(1-2):213-21. PubMed ID: 17448615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nanoparticle infiltration to prepare solvent-free controlled drug delivery systems.
    Rodríguez-Cruz IM; Domínguez-Delgado CL; Escobar-Chávez JJ; Leyva-Gómez G; Ganem-Quintanar A; Quintanar-Guerrero D
    Int J Pharm; 2009 Apr; 371(1-2):177-81. PubMed ID: 19150491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sustained release coating of tablets with Eudragit(®) RS/RL using a novel electrostatic dry powder coating process.
    Qiao M; Luo Y; Zhang L; Ma Y; Stephenson TS; Zhu J
    Int J Pharm; 2010 Oct; 399(1-2):37-43. PubMed ID: 20678560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sulfacetamide loaded Eudragit® RL100 nanosuspension with potential for ocular delivery.
    Mandal B; Alexander KS; Riga AT
    J Pharm Pharm Sci; 2010; 13(4):510-23. PubMed ID: 21486528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Eudragit RS 100 microparticles containing 2-hydroxypropyl-beta-cyclodextrin and glutathione: physicochemical characterization, drug release and transport studies.
    Trapani A; Laquintana V; Denora N; Lopedota A; Cutrignelli A; Franco M; Trapani G; Liso G
    Eur J Pharm Sci; 2007 Jan; 30(1):64-74. PubMed ID: 17118631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eudragit RL 100-based nanoparticulate system of aceclofenac for ocular delivery.
    Katara R; Majumdar DK
    Colloids Surf B Biointerfaces; 2013 Mar; 103():455-62. PubMed ID: 23261566
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation and in vitro dissolution profile of zidovudine loaded microspheres made of Eudragit RS 100, RL 100 and their combinations.
    Nath B; Nath LK; Kumar P
    Acta Pol Pharm; 2011; 68(3):409-15. PubMed ID: 21648196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Poly(ethylene-co-methyl acrylate) membranes as rate-controlling barriers for drug delivery systems: characterization, mechanical properties and permeability.
    Kanis LA; Generoso M; Meier MM; Pires AT; Soldi V
    Eur J Pharm Biopharm; 2005 Aug; 60(3):383-90. PubMed ID: 15996579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet adsorption and hemolytic properties of liquid crystal/composite polymers.
    Shih MF; Shau MD; Chang MY; Chiou SK; Chang JK; Cherng JY
    Int J Pharm; 2006 Dec; 327(1-2):117-25. PubMed ID: 16963207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alcohol enhanced permeation in model membranes. Part I. Thermodynamic and kinetic analyses of membrane permeation.
    Oliveira G; Beezer AE; Hadgraft J; Lane ME
    Int J Pharm; 2010 Jun; 393(1-2):61-7. PubMed ID: 20371274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the sustained release properties of Eudragit RS, RL and S (acrylic resins) microcapsules containing ketoprofen in beagle dogs.
    Goto S; Kawata M; Nakamura M; Nagatsuma Y; Fujinaga K; Aoyama T
    J Microencapsul; 1988; 5(4):343-60. PubMed ID: 3236155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fabrication and characterization of a smart drug delivery system: microsphere in hydrogel.
    Zhang XZ; Jo Lewis P; Chu CC
    Biomaterials; 2005 Jun; 26(16):3299-309. PubMed ID: 15603825
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Crystal growth formation in melt extrudates.
    Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
    Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Moisture plasticization for enteric Eudragit® L30D-55-coated pellets prior to compression into tablets.
    Rujivipat S; Bodmeier R
    Eur J Pharm Biopharm; 2012 May; 81(1):223-9. PubMed ID: 22269937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preparation and characterization of pH- and temperature-sensitive pullulan microspheres for controlled release of drugs.
    Fundueanu G; Constantin M; Ascenzi P
    Biomaterials; 2008 Jun; 29(18):2767-75. PubMed ID: 18396330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.